CD19 and cancer: The field of cell therapy for cancer treatment has gained tremendous momentum as manifested by recent approvals of CD19- and BCMA-targeting autologous CAR T cell therapies and emerging novel allogeneic CAR T and NK cell platforms for solid tumor treatment.